6505--770-24-4-801-0687 - National CMOP BUDESONIDE (VA-24-00098402)
ID: 36C77024Q0387Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/9b58294fe3b94e37b32cc736c91651ca/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting proposals for the procurement of Budesonide 0.5MG/2ML Inhalation Suspension, as outlined in solicitation number 36C77024Q0387. This procurement aims to supply the Consolidated Mail Outpatient Pharmacy (CMOP) locations with essential pharmaceuticals, ensuring compliance with safety, shipping regulations, and the Drug Supply Chain Security Act. Vendors must submit their proposals by September 13, 2024, including a signed SF1449 form, a valid state wholesale distributor license, and a Trade Agreement Act (TAA) certificate, with all products required to have a minimum expiration date of one year from the delivery date. Interested vendors can reach out to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov for further details.

    Point(s) of Contact
    Kelley CunninghamContract Specialist
    kelley.cunningham@va.gov
    Files
    Title
    Posted
    36C77024Q0387_1.docx
    The document outlines a solicitation by the Department of Veterans Affairs, specifically for the procurement of Budesonide 0.5MG/2ML Inhalation Suspension. The contract, referenced as solicitation number 36C77024Q0387, specifies requirements for the pharmaceutical supply to the Consolidated Mail Outpatient Pharmacy (CMOP) locations, emphasizing compliance with safety and shipping regulations. Key points include the requirement for offered products to be shippable by the USPS, proper documentation for tracking, and adherence to specific National Drug Codes (NDCs). Additionally, vendors must provide a valid state wholesale distributor license, and any alternative product codes must be disclosed. The solicitation also mandates barcoding according to industry standards, ensuring traceability and compliance with the Drug Supply Chain Security Act. The delivery schedule is laid out clearly, with quantities assigned to various CMOP shipping destinations, emphasizing prompt delivery timelines. Invoicing terms are specified, including submission processes and adherence to electronic invoicing standards. The document reinforces the government's commitment to maintaining high standards for contracted products, ensuring that all terms align with federal procurement regulations and encourage participation from small businesses.
    36C77024Q0387.docx
    The Department of Veterans Affairs' Network Contracting Office 15 intends to procure Budesonide, a pharmaceutical product, for delivery to several CMOP (Consolidated Mail Outpatient Pharmacy) facilities. The presolicitation notice outlines a requirement for various quantities of Budesonide 0.5mg/2ml inhalation suspension with specific delivery locations indicated, including Leavenworth, Chelmsford, and Tucson. The solicitation number is 36C77024Q0387, classified under the product service code 6505 and NAICS code 325412. The estimated issuance date for the request for quotes (RFQ) is September 6, 2024, with responses due by September 11, 2024. Vendors interested in submission must provide their state wholesale distributor license, a signed solicitation cover page (SF1449), a price schedule in Excel format, and a Trade Agreements Act certificate. Responses should be directed to the specified contracting specialist, Kelley Cunningham. This presolicitation forms part of a competitive procurement process to meet the pharmaceutical needs of the Veterans Affairs healthcare system, ensuring compliance with federal regulations regarding drug distribution.
    36C77024Q0387 0001.docx
    The document pertains to the amendment of a solicitation issued by the Department of Veterans Affairs (VA), specifically regarding RFQ 36C77024Q0387. This amendment updates the initial request by replacing an unacceptable National Drug Code (NDC) with acceptable alternatives. The primary item requested is Budesonide 0.5MG/2ML inhalation suspension, with multiple quantities specified for various locations including Leavenworth, Chelmsford, Tucson, Lancaster, Murfreesboro, Hines, and Ladson. Each shipment is to be delivered FOB Destination within 10 days after receipt of order. Additionally, the amendment underscores compliance with the Trade Agreement Act, emphasizing that bids must come from TAA-compliant countries. All other previously stated terms and conditions of the original solicitation remain unchanged. The amendment aims to ensure that all prospective contractors accurately acknowledge receipt and offer submissions conform to the modified requirements, thereby streamlining the procurement process while maintaining clarity in the contracting obligations.
    S02_Pricing Schedule_Q0387_updated.xlsx
    The document outlines a Request for Quotes (RFQ) from the US Department of Veterans Affairs, specifically for the acquisition of medical supplies through the CMOP system. The RFQ number is 36C77024Q0387, with a submission deadline of September 13, 2024, at 3:00 PM CT. Vendors are required to submit a signed SF1449 form, an Excel quote spreadsheet, a valid State Wholesale Distributor License, and a Trade Agreement Act (TAA) Certificate. All submission documents must meet TAA compliance, and vendors should indicate any short-dated items in their comments. The quote details include specific line items for Budesonide inhalation suspension with varying quantities across multiple CMOP facilities. The primary goal is to ensure the supply of pharmaceuticals meets the stringent quality criteria, particularly a minimum expiration of one year from the delivery date. This RFQ is part of the federal procurement process aimed at fulfilling the VA's needs for essential medical supplies efficiently and effectively.
    S02_Pricing Schedule_Q0387.xlsx
    The document outlines a Request for Quote (RFQ) from the CMOP (Consolidated Mail Outpatient Pharmacy) with the solicitation number 36C77024Q0387, aimed at acquiring specified pharmaceutical supplies. Vendors are required to submit their proposals by September 11, 2024, with all necessary documentation including a signed SF1449 cover page, a quote spreadsheet, a valid state distributor license, and a Trade Agreement Act (TAA) certificate. The quotes must comply with TAA standards, ensuring that all pharmaceuticals have an expiration date of at least one year from the delivery date. The RFQ details various line items, including quantities and product specifications such as the NDC (National Drug Code) for Budesonide. Proposals are to be emailed to a designated point of contact at the VA, and adjustments in quantities must be noted if a vendor proposes alternative codes. This solicitation represents a critical step in the procurement process to enhance the availability of essential medical supplies within the federal healthcare system. The deadline and compliance requirements signify the structured approach of government procurement aimed at ensuring quality and regulatory adherence in healthcare supply chains.
    Similar Opportunities
    6505--Bupropion Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Bupropion Hydrochloride tablets, aimed at supporting veterans and related entities through its Pharmaceutical Prime Vendor Programs. Offerors are required to submit pricing that includes a 0.5% Cost Recovery Fee and provide unique National Drug Code (NDC) numbers for their products, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and FDA regulations. This procurement is crucial for maintaining a reliable pharmaceutical supply for VA healthcare facilities, with an emphasis on participation from small and disadvantaged businesses. Interested parties can reach out to Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further details.
    6505--Prasugrel HCL 5mg and 10mg 30 Count Bottles
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Prasugrel Hydrochloride (HCL) tablets in 5mg and 10mg 30 count bottles. The procurement aims to establish a reliable supply chain for these pharmaceutical products, which are critical for the healthcare of veterans and related agencies, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). Offerors must provide pricing for a base year and four optional one-year periods, demonstrate manufacturing and distribution capabilities, and adhere to stringent reporting and safety standards. Interested contractors should contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov for further details regarding the solicitation process.
    6505--Abiraterone Acetate Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the procurement of Abiraterone Acetate Tablets, identified by solicitation number 36E79724R0023. This procurement aims to secure a reliable supply of these pharmaceutical products for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare entities, emphasizing the need for uninterrupted supply and compliance with specific labeling and packaging requirements. The estimated annual requirements include 71,997 bottles of 120-count 250mg tablets and 1,102 bottles of 60-count 500mg tablets, with the RFP scheduled for electronic release on approximately September 18, 2024, and a closing date of October 2, 2024. Interested vendors can direct inquiries to Contract Specialist Richard Mahario at Richard.Mahario@va.gov or by phone at 708-786-5247, and must regularly check SAM.gov for updates as no paper copies of the solicitation will be provided.
    6505--770-24-4-801-0686 -National CMOP CLINDAMYCIN -(VA-24-00096153)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Clindamycin PO4 1% Top Swab for delivery to multiple Compounding Medication Outpatient Pharmacies (CMOP) across the country. This procurement aims to secure approximately 3,584 units of the specified pharmaceutical product, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). The goods are essential for the VA's healthcare services, supporting the treatment of various medical conditions. Interested vendors must submit their quotations by September 6, 2024, including a signed SF1449 cover page, a price schedule, proof of a valid State Wholesale Distributor License, and a Buy American Act Certificate. For further inquiries, vendors can contact Kelley Cunningham at kelley.cunningham@va.gov or call 913-684-0140.
    8145--Medication Return Envelopes (VA-24-00012799)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Medication Return Envelopes under solicitation number 36C77024Q0051. This initiative aims to supply multiple Veterans Affairs Medical Centers (VAMCs) and Consolidated Mail Outpatient Pharmacies (CMOP) with a system for the safe disposal of scheduled and non-controlled medications over a five-year period, from November 2024 to October 2029. The program is critical for enhancing medication safety, preventing accidental overdoses, and reducing environmental waste, with an estimated budget of $47 million. Interested vendors must submit their bids by October 14, 2024, at 5 PM Central Time, and are encouraged to monitor SAM.gov for further solicitation details, which will be posted on September 13, 2024. For inquiries, contact Contract Specialist Diana Olson at Diana.Olson@va.gov or 913-684-0153.
    6505--766-24-4-400-1189 -Charleston CMOP SUMATRIPTAN -(VA-24-00096608)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of SUMATRIPTAN 6MG/0.5ML Injection Syringe for the Charleston Consolidated Mail Outpatient Pharmacy (CMOP) in Ladson, South Carolina. This procurement requires vendors to submit a comprehensive quote that adheres to strict delivery and documentation requirements, including a completed Excel quote spreadsheet, a signed SF1449 cover page, and proof of a valid State Wholesale Distributor License, along with a Buy American Act Certificate. The pharmaceuticals must have an expiration date of no less than one year from the delivery date, ensuring compliance with quality standards. Interested vendors must submit their quotes by September 17, 2024, at 3:00 PM Central Time, and can direct inquiries to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79724R0027, aimed at procuring Norethindrone Acetate Tablets (5mg) for various federal entities, including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and State Veterans Homes (SVH). The successful offeror will be required to provide an uninterrupted supply of the tablets, with a contract period of one year and four optional renewal years, and must adhere to specific labeling and packaging standards, including a unique NDC number and safety-cap design. This procurement is critical for ensuring the availability of essential medication for veterans and other federal health care facilities, with an estimated annual requirement of 13,202 bottles, each containing 50 tablets. Interested parties should submit their proposals by November 1, 2023, following the electronic release of the solicitation on or about October 18, 2023, and can direct inquiries to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov.
    6505--Zolmitriptan Tablets (VA-25-00006129)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of Zolmitriptan tablets, as outlined in solicitation number VA-25-00006129. This contract aims to establish a reliable source of pharmaceutical supplies for federal healthcare programs, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and good manufacturing practices as mandated by the FDA. The selected contractor will be responsible for providing competitive pricing for both the base year and four option years, ensuring that all products meet safety and regulatory standards. Interested parties should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further details and to discuss submission requirements.
    762-24-3-040-2385 -Tucson CMOP ACAMPROSATE -(VA-24-00083915)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking offers for the procurement of Acamprosate 333mg EC tablets under solicitation number 36C77024Q0392, aimed at fulfilling its pharmaceutical needs. Vendors are required to submit a comprehensive proposal that includes pricing schedules, valid state licenses, and compliance certifications, with a focus on maintaining high standards for drug quality and adherence to regulatory requirements. This procurement is crucial for ensuring the availability of essential medications for veterans, reflecting the government's commitment to supporting small businesses through a total small business set-aside. Interested vendors must submit their bids by September 17, 2024, at 4:00 PM CST, and can contact Sarah Fry at sarah.fry2@va.gov or 913-758-9935 for further information.
    Q517--Hazardous Compounding
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for hazardous compounding services to support the Gulf Coast Veterans Health Care System, specifically for providing compounded hazardous chemotherapy agents at its facilities in Biloxi, MS, and Pensacola, FL. The contract will be structured as a firm-fixed price, indefinite-delivery, indefinite-quantity agreement, with a base period from October 1, 2024, to September 30, 2025, and the option for four additional one-year extensions. This procurement is critical for ensuring the timely and compliant delivery of essential medical treatments to veterans, adhering to FDA and USP standards while emphasizing quality assurance and regulatory compliance. Interested contractors should submit their proposals and past performance questionnaires by 12 PM CT on September 20, 2024, and can direct inquiries to Contracting Officer Tina L. Harris at Tina.Harris3@va.gov.